Insulin resistance in early vs late nutrition and complications of sirs in neurosurgical intensive care unit (ICU)

Med Arch. 2015 Feb;69(1):46-8. doi: 10.5455/medarh.2015.69.46-48. Epub 2015 Feb 21.

Abstract

Background: Systemic Inflammatory Response Syndrome (SIRS) is a common complication in neurosurgical diseases in Intensive Care Unit (ICU). Because of associated insulin resistance (IR) the ICU is in dilemma in which stage to start the nutrition to patients and what is the amount of Insulin Unit to control the hyperglycemia.

Aim: to define the IR and to compare IR and amount of insulin among ICU patients in "Mother Theresa" University Hospital Center (MTUHC) in Tirana Albania.

Methods: 154 patients with neurosurgical disease and SIRS complications were randomized in two groups: early nutrition 73 patients (47%) and late nutrition 81 (53%) and compared for a number of variables.

Results: There was no statistical age and gender difference between the two groups (P>0.05). The amount of insulin units to control the level of glycemia (80-110 mg/dc) was 12.8±7 unit per day in early nutrition and 23.8 ±12.9 units in late nutrition group (p<0.01). No patient in early nutrition group but six (7.4%) patients in late nutrition group developed insulin resistance (p=0.03).

Conclusions: the IR due to the infection complications is higher among late than early nutrition group. Therefore, we suggest that in neurosurgical ICU it would be better to start the nutrition within 72 hours.

Keywords: Albania; Insulin resistance; Intensive care unit; early nutrition; late nutrition; neurosurgical complication.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Albania / epidemiology
  • Female
  • Humans
  • Insulin / therapeutic use*
  • Insulin Resistance*
  • Intensive Care Units / statistics & numerical data
  • Male
  • Middle Aged
  • Nervous System Diseases / complications*
  • Nutrition Therapy / methods*
  • Prospective Studies
  • Systemic Inflammatory Response Syndrome / complications*
  • Systemic Inflammatory Response Syndrome / epidemiology
  • Systemic Inflammatory Response Syndrome / therapy*
  • Time-to-Treatment*

Substances

  • Insulin